Skip to main content

The Commission is now operating in accordance with the Caretaker ConventionsExternal link pending the outcome of the 2025 federal election.

2024
Newsletter

This issue includes items on the new Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard, digital technology, remote or telehealth, nursing care, end of life care, patient perspectives, COVID-19, and more. 

Also covered are the latest from BMJ Quality & Safety, Journal for Healthcare Quality (JHQ), Health Affairs, Health Affairs Scholar and International Journal for Quality in Health Care along with the latest from the UK’s NICE and the USA’s AHRQ.

MEDIA RELEASE

Today marks a significant milestone in health care as the Australian Commission on Safety and Quality in Health Care (the Commission) introduces a national standard to improve the care of people with cognitive disability or impairment.

The Commission is seeking your feedback on the draft Aged Care Infection Prevention and Control (IPC) Guide.

2024
Media release

Psychotropic medicines are commonly prescribed to people with cognitive disability or impairment, including older people with dementia and people of all ages with intellectual disability, autism spectrum disorder and other neurodevelopmental conditions. Psychotropic medicine use in these populations is disproportionately high, reflecting a concerning trend in healthcare practices.

Back to top